A strain of Lactobacillus plantarum HYZQF 1675 iso-3 and its application

Through the development of Lactobacillus plantarum HYZQF 1675 Iso-3, the problem that existing probiotics do not have anti-cancer effects has been solved, and the balance of intestinal bacteria is achieved is achieved, and the anti-cancer substances and attenuation effect is provided, which significantly improves cancer prevention and intestinal prevention and intestinal prevention Health level.

CN118599740BActive Publication Date: 2024-11-08SHANDONG HUANYI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411080504.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-08
Estimated Expiration
2044-08-08

AI Technical Summary

Technical Problem

Not all existing probiotics have anti-cancer effects, which limits their promotion in anti-cancer applications. New probiotic strains with anti-cancer effects need to be found.

Method used

A plant Lactobacillus HYZQF 1675 Iso-3 was developed. This strain not only has anti-cancer effects, but also has attenuation effect. It provides Centella Snow Grass by regulating the balance of intestinal bacteria and promoting digestion and absorption, and can reproduce and grow in the intestine. Advantageous substances such as glycoside, centella asoxalic acid, kaempol, radishellin, ellagic acid, glutathione, etc. inhibit mycotoxins and reduce heavy metal content.

Benefits of technology

This strain can prevent the occurrence of cancer, maintain the health of the body, significantly inhibit mytoxins, reduce the content of heavy metals in the blood, and effectively degrade pesticides, improving intestinal health and immune function.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present invention belongs to the field of microbial technology and relates to a plant lactobacillus HYZQF 1675 iso-3 and its application. The plant lactobacillus HYZQF 1675 iso-3 is deposited in the China Center for Type Culture Collection with a deposit number of CCTCC NO: M2019190. The strain provided by the present invention has the effects of regulating the balance of intestinal flora and promoting human digestion and absorption, as well as anti-cancer and detoxification.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms and relates to a strain of Lactobacillus plantarum HYZQF 1675 iso-3 and application thereof. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Cancer is a malignant tumor. It is the disease with the highest incidence and the longest treatment course in my country and the world. It has become one of the public health issues that affect human health and life span. More than 10 million people are diagnosed with cancer every year in the world, and about 6.2 million people lose their lives. With the development of the economy, people's awareness of cancer prevention and anti-cancer has gradually increased. Among anti-cancer foods, people are paying more and more attention to probiotics. Reports have shown that some probiotics have anti-cancer activity, and this anti-cancer function does not work from a single factor, but from multiple pathways. From the perspective of action, it can be divided into direct action and indirect action. The direct action is the binding or conversion inactivation of carcinogens by the bacteria themselves or their active metabolites; the indirect action is to play an anti-cancer function by regulating the intestinal flora and its metabolic enzyme activity, regulating the enzyme activity related to host detoxification, and regulating immune function.

[0004] However, not all probiotics have anti-cancer effects, which limits the promotion of probiotics in anti-cancer applications. Therefore, it is necessary to find new probiotics with anti-cancer effects. Summary of the invention

[0005] In order to solve the deficiencies of the prior art, the present invention aims to provide a strain of Lactobacillus plantarum HYZQF 1675 iso-3 and its application. Studies have shown that the strain not only has anti-cancer efficacy, but also has a detoxification effect.

[0006] In order to achieve the above object, the technical solution of the present invention is:

[0007] In the first aspect, a strain of Lactobacillus plantarum HYZQF 1675 iso-3 is deposited in China Center for Type Culture Collection with a deposit number of CCTCC NO: M2019190.

[0008] The strain provided by the present invention was isolated from fresh Centella asiatica in Urumqi, Xinjiang Uygur Autonomous Region in September 1997 and identified as Lactobacillus plantarum by 16srRNA method. The strain has the effects of regulating the balance of intestinal flora and promoting human digestion and absorption, as well as anti-cancer and detoxification.

[0009] In a second aspect, a method for culturing the above-mentioned Lactobacillus plantarum HYZQF 1675 iso-3 is provided, and the Lactobacillus plantarum HYZQF 1675 iso-3 is obtained by culturing the above-mentioned Lactobacillus plantarum HYZQF 1675 iso-3.

[0010] In some embodiments, the culture temperature is 36-38°C.

[0011] In some embodiments, the culturing includes expansion culture, primary seed culture, seed tank culture, and fermentation in sequence.

[0012] In some embodiments, the culture includes expanded culture, and the conditions of the expanded culture are: 36-38°C for 18-24 hours. Specifically, the culture medium for expanded culture contains: yam polysaccharide 9-11g, glucose 3.5-4.5g, beef extract powder 1.5-2.5g, yeast extract powder 2.5-3.5g, sodium acetate 1.5-2.5g, Tween-80 0.4-0.6 mL, potassium dihydrogen phosphate 0.15-0.25g per 1000mL water; pH is 6.9-7.1.

[0013] In some embodiments, the culture includes primary seed culture, and the conditions of the primary seed culture are: culture at 36-38°C for 28-36 hours. Specifically, in the culture medium of the primary seed culture, per 1000mL of water, there are: 2.5-3.5g of stachyose, 0.8-1.2g of glucose, 0.8-1.2g of peptone, 6-8g of oligoxylose, 0.8-1.2g of beef extract powder, 1.5-2.5g of yeast extract powder, 1.5-2.5g of taurine, 0.15-0.25g of sodium acetate, 2.5-3.5g of threonine, and 0.8-1.2mL of Tween-80.

[0014] In some embodiments, the culture includes seed tank culture, and the conditions of the seed tank culture are: tank pressure of 0.045-0.055 MPa, 36-38 ° C culture for 22-26 hours. Specifically, the culture medium of the seed tank culture includes, by mass percentage: 0.8-1.2% oligofructose, 0.45-0.55% glucose, 0.7-0.9% lactitol, 0.8-1.0% casein peptone, 0.6-0.8% dipotassium hydrogen phosphate, 0.8-1.0% lysine, 0.08-0.12% sodium acetate, 1.1-1.3% cystine, 0.08-0.12% Tween-80, 0.08-0.12% polyether defoamer, and the balance is water.

[0015] In some embodiments, the culture includes fermentation, and the fermentation conditions are: tank pressure of 0.045-0.055 MPa, culturing at 36-38 ° C for 23-27 h, and pH of 5.7-5.9. Specifically, the fermentation medium includes, by mass percentage: 0.8-1.2% glucose, 0.45-0.55% oligofructose, 2.5-3.5% water-soluble corn starch, 0.45-0.55% casein peptone, 2.5-3.5% yeast extract powder, 1.3-1.7% sodium acetate, 0.15-0.25% Tween-80, 0.8-1.2% fish collagen, 0.7-1.1% dipotassium hydrogen phosphate, 0.08-0.12% polyether defoamer, and the balance is water.

[0016] In a third aspect, a derivative of the above-mentioned Lactobacillus plantarum HYZQF 1675 iso-3 is provided, wherein the derivative is a living bacterium, a dead bacterium, a fermentation broth or a metabolite.

[0017] In a fourth aspect, a composition comprises the above-mentioned Lactobacillus plantarum HYZQF 1675 iso-3 or its derivatives.

[0018] In some embodiments, the composition is a pharmaceutical composition, a food composition, a health food composition, a nutritional composition, a dietary supplement composition, a cosmetic composition or a feed composition. The food composition can be a baked food, a solid beverage, a liquid beverage, a compressed candy, etc.

[0019] In some embodiments, the composition is in the form of lyophilized powder, injection, pill, tablet, capsule or gel candy.

[0020] In some embodiments, the composition includes an auxiliary material. Specifically, the auxiliary material includes one or more of an excipient, a disintegrant, a lubricant, a sweetener, and a binder. More specifically, it includes one or more of water-soluble corn starch, anhydrous glucose, resistant dextrin, glycine, and magnesium gluconate.

[0021] In a fifth aspect, a use of the above-mentioned Lactobacillus plantarum HYZQF 1675 iso-3, derivative or composition in the preparation of a product; the product is any one of the following products:

[0022] (1) Products for the treatment of cancer;

[0023] (2) Products that increase the content of one or more of asiaticoside, asiatic acid, kaempferol, glucoraphanin, ellagic acid, and glutathione in the intestine;

[0024] (3) Products that inhibit mycotoxins;

[0025] (4) Products that reduce the level of heavy metals in the blood;

[0026] (5) Products that degrade pesticides.

[0027] The beneficial effects of the present invention are:

[0028] The plant lactobacillus HYZQF 1675 iso-3 provided by the present invention has the effect of regulating the balance of intestinal flora and promoting human digestion and absorption, and also has the effect of anti-cancer. Daily administration of 900 million strains of the present invention and 130 mg of metabolites can sustainably provide the endogenous necessary amount of asiaticoside, asiatic acid, kaempferol, glucoraphanin, ellagic acid and glutathione during the intestinal reproduction and growth process. It can prevent the occurrence of cancer and keep the body healthy. In addition, the plant lactobacillus HYZQF 1675 iso-3 provided by the present invention also has the effect of reducing toxicity, specifically inhibiting fungal toxins, reducing the content of heavy metals in human blood and degrading pesticides. DETAILED DESCRIPTION

[0029] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.

[0030] Example

[0031] The strain used in this example is Lactobacillus plantarum HYZQF 1675 iso-3 ( Lactobacillus plants HYZQF 1675 iso-3), was deposited in China Center for Type Culture Collection (CCTCC) on March 22, 2019, at Wuhan University, Wuhan, China, and its biological deposit number is CCTCC NO: M2019190.

[0032] Bacterial strain culture: Expansion culture of bacterial strains preserved in -80℃ refrigerator.

[0033] Preparation of culture medium: 10g yam polysaccharide, 4g glucose, 2g beef extract powder, 3g yeast extract powder, 2g sodium acetate, 0.5mL Tween-80, 0.2g potassium dihydrogen phosphate, 1000mL tap water, pH adjusted to 7.0 (alkaline solution adjustment).

[0034] Operation: Add the yam polysaccharide and other raw materials in the above formula into 1000mL of water in the formula without any distinction, stir for 10 minutes to dissolve, and then divide into test tubes, each test tube contains 5mL, seal with kraft paper and put in a medical sterilizer for sterilization at 0.11MPa for 20 minutes. The culture medium is ready.

[0035] Inoculation: Under sterile conditions (clean bench), open the -80℃ low-temperature refrigerator to store the frozen tube of bacteria, dissolve it at room temperature, then take one sterilized test tube culture medium, add 0.5mL of the dissolved bacterial solution into the test tube, seal the tube mouth with kraft paper, shake it gently by hand, put it in a constant temperature incubator at 37℃ and culture it for 20 hours. This is called expansion culture medium.

[0036] Primary seed culture formula: stachyose 3g, glucose 1g, peptone 1g, xylo-oligosaccharide 7g, beef extract powder 1g, yeast extract powder 2g, taurine 2g, sodium acetate 0.2g, threonine 3g, Tween-80 1mL, tap water 1000mL.

[0037] Operation: Add the above raw materials into 1000mL of tap water without any distinction, start the blender, and stir for 10 minutes to dissolve them all. This is called the primary seed culture solution.

[0038] Add the stirred and dissolved first-grade seed culture solution into the triangular flask according to the dosage, then wrap the bottle mouth with 6 layers of gauze and a layer of kraft paper, and put it into the sterilizer for sterilization. Before sterilization, first open the exhaust valve on the sterilizer, and close it when a small amount of steam is discharged. When the pressure on the sterilizer reaches 0.05MPa, open the exhaust valve on the sterilizer to exhaust for 6-8 minutes, then close the exhaust valve and continue heating. When the steam pressure in the sterilizer reaches 0.11 MPa, start timing, the sterilization time is 20min, leave the heat source after completion, let it cool down naturally, when the pressure gauge on the sterilizer returns to zero, open the sterilizer, take out the sterilized culture medium and put it into the clean workbench to cool down naturally. When the temperature drops to 37℃, transfer the above cultured expanded bacterial liquid to the triangular flask containing sterilized culture medium, and the inoculation amount is 0.5%, that is, 100mL of primary seed culture medium and 0.5mL of expanded bacterial liquid. After completion, seal the bottle mouth with the original gauze and kraft paper, shake it slightly by hand to mix the connected bacteria and culture medium evenly, and then put it in a constant temperature box and culture it at 37℃ for 30h. This is called the primary bacterial liquid.

[0039] Sterilization of fermentation equipment, pipelines and sterile filtration systems:

[0040] First, open the valves of all inlet and outlet pipelines and sterile air pipelines, pass 0.13 MPa steam, allow the steam to connect with the pipeline valves and discharge a small amount of steam, ventilate for 40 minutes, and then close the valves of all inlet and outlet pipelines for standby use.

[0041] Sterilization of empty seed tanks and fermentation tanks:

[0042] Close all valves, open the drain valve at the bottom of the tank and the drain valve in the tank interlayer, open the direct steam valve to introduce 0.13 MPa steam into the pipe, start timing when the temperature in the tank reaches 121°C, the sterilization time is 40 minutes, then close the drain valve at the bottom of the tank and the drain valve in the interlayer, and the temperature in the tank will naturally drop to 37°C for standby use.

[0043] Seed pot culture:

[0044] Formula: 1% oligofructose, 0.5% glucose, 0.8% lactitol, 0.9% casein peptone, 0.7% dipotassium hydrogen phosphate, 0.9% lysine, 0.1% sodium acetate, 1.2% cystine, 0.1% Tween-80, 0.1% polyether defoamer, and 93.8% tap water.

[0045] Specific operation: First, pour the tap water used in the formula into the sterilized seed tank, start the mixer, add the raw materials required in the formula respectively (the order of addition is not important), then stir continuously and pass steam for heating. First, use the steam in the tank interlayer to heat to 95°C, then switch to direct steam heating. When the temperature in the tank reaches 121°C, maintain it for 20 minutes to achieve the sterilization effect, then turn off the steam, and start cooling through the tap water in the tank interlayer. When the temperature in the tank reaches 37°C, it is ready for use. This is called seed culture medium. Then inoculate the above-cultured first-level bacterial culture solution into the seed tank under sterile conditions. The inoculation amount is 3% of the culture medium in the tank. 100 kg of seed tank culture medium can be inoculated with 3 kg of first-level bacterial solution. Then cover the inoculation cap on the tank and start stirring and culturing. The culture conditions are: temperature 37°C, stirring speed 140r / min, tank pressure 0.05MPa, and culture time 24h to meet the requirements. If the tank body is lowered, sterile air can be introduced to maintain the tank pressure. If the tank pressure is too high, the air release valve on the tank top can be used to adjust it. This is called seed tank culture.

[0046] Fermentation

[0047] Formula: 1% glucose, 0.5% oligofructose, 3% water-soluble corn starch, 0.5% casein peptone, 3% yeast extract powder, 1.5% sodium acetate, 0.2% Tween-80, 1% fish collagen, 0.9% dipotassium hydrogen phosphate, 0.1% polyether defoamer, and 88.3% tap water.

[0048] Specific operation: First, add the tap water used in the formula into the sterilized fermentation tank, start the mixer, add the raw materials used in the formula into the fermentation tank (the order of addition is not important), and then pass steam for heating. First, use the interlayer steam to heat to 95°C, and then switch to direct steam heating. When the temperature in the tank reaches 121°C, start timing, and keep it for 30 minutes to achieve the sterilization effect, and then cool it down with the tap water in the interlayer. When the temperature in the tank drops to 37°C, start to inoculate the strains. Before inoculation, first increase the tank pressure of the seed tank to 0.1MPa, and keep the tank pressure of the fermentation tank at 0.05MPa, then open the inoculation pipeline valve, and transport the seeds cultured in the seed tank to the fermentation tank by pressure difference, and then close the inoculation channel valve.

[0049] The inoculation amount is 3 kg of bacteria cultured in the seed tank for every 100 kg of culture medium in the fermentation tank. The culture conditions are: culture temperature 37°C, stirring speed 160r / min, tank pressure maintained at 0.05MPa, and the acid and alkali automatic control system is used to maintain the pH value of 5.8 during the fermentation process. If the tank pressure drops, sterile air can be introduced to maintain the tank pressure until the fermentation is completed. The total fermentation time is 25 hours, and then the temperature is lowered to 20°C. This is the fermentation broth. 2% sterile glycerol (95%) is added to the fermentation broth and kept at 120°C for 5 seconds for UHT inactivation treatment.

[0050] Fermentation broth centrifugation

[0051] The fermentation liquid is pumped into a storage tank for centrifugation. Operation: Start the centrifuge, adjust the speed to 10000r / min, centrifuge at a feed rate of 8kg / min, collect the wet bacterial sludge metabolites after centrifugation, and freeze-dry the collected wet bacterial sludge metabolites.

[0052] Freeze-drying of bacterial sludge metabolites

[0053] Preparation of bacterial suspension: Take 1000 g of inactivated wet bacterial sludge metabolites, add 4000 mL of sterile physiological saline, 400 g of water-soluble corn starch, 700 g of anhydrous glucose, 700 g of resistant dextrin, 20 g of glycine, and 70 g of magnesium gluconate.

[0054] Operation: First, take 2500mL of sterile saline in the formula, add resistant dextrin and stir to dissolve, then add 1000g of inactivated wet bacterial sludge metabolites, and then add the remaining sterile saline and anhydrous glucose and auxiliary materials in the formula and stir well, which is called a suspension. The suspension is freeze-dried and the moisture content is finally controlled to 4%, which becomes a freeze-dried powder of inactivated bacterial metabolites.

[0055] Metabolomics analysis

[0056] Metabolomics analysis of mouse feces was performed using ultra-performance liquid chromatography-tandem mass spectrometry.

[0057] Experimental plan: The mice were divided into a control group and an experimental group. The control group was fed normally, while the experimental group was added with the above-mentioned freeze-dried powder of inactivated bacterial metabolites (a probiotic product containing 900 million inactivated bacterial cells and 130 mg of metabolites) in their food. After ten days of feeding, fecal samples of the mice in the control group and the experimental group were placed in 400 μL of extraction solution (acetonitrile: methanol = 1:1), vortexed for 30 seconds, and subjected to low-temperature ultrasonic extraction for 30 minutes (5°C, 40 KHz), allowed to stand at -20°C for 30 minutes, placed in a 4°C centrifuge, and centrifuged at 13000 r / min for 15 minutes. The supernatant was taken, dried with nitrogen, and re-dissolved with 120 μL of re-solution (acetonitrile: water = 1:1). After low-temperature ultrasonic extraction for 5 minutes (5°C, 40 KHz), the sample was placed in a 4°C centrifuge, and centrifuged at 13000 r / min for 5 minutes. An appropriate amount of supernatant was taken for analysis. 10uL of sample supernatant was separated by BEH C18 column (100mm ×2.1mm id, 1.8µm) and entered mass spectrometry detection. The separation flow rate was 0.40mL / min and the column temperature was 40℃. After completion, the LC-MS raw data was transferred to the computer for processing and analysis. The MS mass spectrum information was matched with the public database, and the main metabolite information was obtained as shown in Table 1.

[0058] Table 1 Main metabolomics analysis of probiotic-fed mice

[0059]

[0060] Table 1 shows that the use of Lactobacillus plantarum HYZQF 1675 iso-3 can significantly increase the content of asiaticoside, asiatic acid, kaempferol, glucoraphanin, ellagic acid, and glutathione in mouse feces. This shows that Lactobacillus plantarum HYZQF 1675 iso-3 can sustainably provide the endogenous necessary amount of asiaticoside, asiatic acid, kaempferol, glucoraphanin, ellagic acid, and glutathione during the intestinal reproduction and growth process.

[0061] The freeze-dried powder of the inactivated bacterial metabolite prepared above is used for anti-cancer applications.

[0062] In this application trial, the subjects were gastric cancer, colon cancer, and cervical cancer patients with an average age of 59 in 20 communities in Jinan City. As of December 2018, a total of 160 people were recruited to participate in the experiment. All of the above patients signed a written informed consent form. If the participant was unable to sign, an agent (usually a family member) would sign it.

[0063] The prepared inactivated bacterial metabolite freeze-dried powder was administered to cancer patients. The administration of the inactivated bacterial metabolite freeze-dried powder by cancer patients and the inactivated bacterial metabolite freeze-dried powder in the application test is shown in Table 2.

[0064] Table 2 Cancer patients and the use of freeze-dried powder of inactivated bacterial metabolites

[0065]

[0066] In the gastric cancer group, 30 people started to collect the results after taking the medicine for 25 days. After taking it for 25 days, 8 people felt the degree and frequency of stomach pain, loss of appetite, and improved postoperative inflammation and constipation. After taking it for 50 days, 16 people felt the degree and frequency of stomach pain, loss of appetite, and significant improvement in postoperative inflammation and constipation. After taking it for 75 days, 23 people felt the degree and frequency of stomach pain, loss of appetite, and significant improvement in postoperative inflammation and constipation. After taking it for 90 days, 28 people felt the degree and frequency of stomach pain, loss of appetite, and complete improvement in postoperative inflammation and constipation, and Helicobacter pylori was completely eradicated after taking it for 150 days. A total of 2 people did not improve after taking Lactobacillus plantarum.

[0067] In the colorectal cancer group, 30 people started to collect the results after taking it for 25 days. After taking it for 25 days, 6 people felt that diarrhea, vomiting, constipation, nausea, mucositis and other conditions had improved. After taking it for 50 days, 15 people felt that diarrhea, vomiting, constipation, nausea, and mucositis had been significantly improved. After taking it for 75 days, 19 people had extremely obvious improvements in diarrhea, vomiting, constipation, nausea, and mucositis. After taking it for 90 days, 26 people had completely improved their diarrhea, vomiting, constipation, nausea, and mucositis. After taking it for 150 days, the levels of pro-inflammatory cytokines, TNF-α, IL-6, IL-10, IL-12, IL-17A, IL-17C, and IL-22 decreased. A total of 4 people did not improve after taking Lactobacillus plantarum.

[0068] In the cervical cancer group, 20 people started to collect the results after taking the medicine for 25 days. After taking it for 25 days, 5 people felt that vaginal bleeding, watery secretions, nausea, vomiting and diarrhea caused by radiotherapy and chemotherapy had improved. After taking it for 50 days, 9 people felt that vaginal bleeding, watery secretions, nausea, vomiting and diarrhea caused by radiotherapy and chemotherapy had improved significantly, and immunity also increased. After taking it for 75 days, 13 people had vaginal bleeding, watery secretions, nausea, vomiting and diarrhea caused by radiotherapy and chemotherapy. After taking it for 90 days, 18 people had completely improved their vaginal bleeding, watery secretions, nausea, vomiting and diarrhea caused by radiotherapy and chemotherapy. After taking it for 100 days, the nutritional index and immune index of the patients were significantly improved. After taking it for 150 days, the HPV negative conversion rate reached 92%. A total of 2 people did not improve after taking Lactobacillus plantarum.

[0069] The freeze-dried powder of the inactivated bacterial metabolites prepared above is used for attenuated application.

[0070] (1) Inhibition of fungal toxins:

[0071] Mycotoxins are absorbed in the upper part of the gastrointestinal tract, but the degree of absorption varies greatly, ranging from more than 80% (aflatoxin) to less than 10% (fumonisin). Many mycotoxins can penetrate the skin, but the doses do not seem to be high enough to cause serious health problems. This example uses aflatoxin as an example to perform an experiment to inhibit mycotoxins. The experimental operation is as follows: take 15mL of high-temperature sterilized PDA culture medium and place it in a culture dish. After the culture medium condenses, add 2μL of a flavus spore suspension (10 6 spores / mL) were inoculated in the center of the culture medium, a sterile filter paper was pasted on the lid of the culture dish, 10 μL of freeze-dried powder containing inactivated bacterial metabolites (900 million inactivated bacterial cells and 130 mg of metabolites of probiotic products) was dripped on the sterile paper, and after absorption, sterile water was used for the control group, the culture dish was covered, the culture dish was sealed with a sealing film, and placed in a constant temperature incubator (28°C) for 7 days, and each test was repeated 3 times. The diameter of the colony was measured every day, and the cross method was used to determine it twice, and the results were averaged. Mycelium inhibition rate = (dc-dt) / dc×100%, where dc and dt are the average values ​​of the colony diameters of the control group and the treatment group, respectively.

[0072] After treating aflatoxin at 28℃ for 7 days, the production of aflatoxin was inhibited by 99%.

[0073] (2) Heavy metal detoxification:

[0074] Most heavy metals are carcinogenic to humans (such as as, cadmium, and chromium) or potentially carcinogenic (lead). After oral poisoning, the gastrointestinal tract is the first organ where metals are absorbed, but once they enter the blood, they accumulate mainly in the kidneys and liver. In addition, long-term exposure to cadmium and lead to calcium homeostasis, mitochondrial damage and oxidative stress, leading to lipid peroxidation and DNA fragmentation. The subjects were heavy metal poisoning people with an average age of 40 years old in five communities in Jinan City. As of December 2019, a total of 20 people were recruited to participate in the experiment. All the above patients signed written informed consent forms. If the participants were unable to sign, they were signed by agents (usually family members). The freeze-dried powder of inactivated bacterial metabolites prepared above was used for patients with heavy metal poisoning. The administration of freeze-dried powder of heavy metal poisoning patients and inactivated bacterial metabolites in the application test is shown in Table 3.

[0075] Table 3 Patients with heavy metal poisoning and the use of freeze-dried powder of strains

[0076]

[0077] Oral probiotics have a significant effect on the human body poisoned by heavy metals. By consuming this probiotic, they can detoxify different organs and tissues. After 90 days of oral administration of this probiotic, the lead level in the blood of young people is normal, and the mercury and arsenic levels in the blood of pregnant women with long-term exposure are normal.

[0078] (3) Degradation of pesticides:

[0079] The toxic effects of pesticides on the human body include neurotoxicity, skin irritation, carcinogenicity and endocrine disruption. Pesticides include organochlorine, organophosphorus, neonicotinoids, benzimidazoles, carbamates and synthetic pyrethroids. They can accumulate in adipose tissue and milk. They are highly persistent in the environment. This example uses the above strains to conduct pesticide degradation experiments. The experimental operation is as follows:

[0080] Stone-free and pollution-free soil samples were collected, and trichlorfon was added to all of them, so that the final concentration of soil pesticides was 500 mg / kg. The pesticide-contaminated soil without the addition of probiotic products was used as a blank control. The experimental group added probiotic products (containing 900 million inactivated bacterial cells and 130 mg of metabolites) at different concentrations (0.01 mg / mL, 0.05 mg / mL, 0.1 mg / mL) and placed at room temperature. 7 days after the application of the pesticide, the soil samples were taken, packed in sealed bags, and stored in a refrigerator at -20°C for testing. Weigh 4.5g of the experimental soil in a test tube, add 2 times the volume of ethyl acetate for ultrasonic extraction for 30 minutes, let it stand and take the supernatant, and extract three times in total. The extracted ethyl acetate was passed through an ODS C18 column, the solution was collected and evaporated to dryness, and then dissolved in methanol and evaporated. The sample was dissolved in chromatographic methanol and passed through a 0.22μm organic filter membrane. The content was detected by high-performance liquid chromatography, and the degradation rate was calculated, as shown in Table 4.

[0081] Table 4 Degradation rate of trichlorfon pesticide by probiotic products

[0082]

[0083] The experimental results show that when the concentration of probiotics is 0.05 mg / mL, the degradation rate of trichlorfon can reach 96%.

[0084] The nucleic acid sequence of the above strains by 16srRNA method is as follows:

[0085]

[0086] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A strain of Lactobacillus plantarum HYZQF 1675 iso-3, characterized in that: It is deposited in China Center for Type Culture Collection with the deposit number CCTCC NO: M2019190.

2. A method for culturing Lactobacillus plantarum HYZQF 1675 iso-3 according to claim 1, characterized in that: The Lactobacillus plantarum HYZQF 1675 iso-3 is cultured to obtain the product.

3. The culture method of plant lactobacillus HYZQF 1675 iso-3 as claimed in claim 2, characterized in that, The culture temperature is 36~38 ℃.

4. The method for cultivating Lactobacillus plantarum HYZQF 1675 iso-3 as claimed in claim 2, characterized in that: The culture includes expansion culture, primary seed culture, seed tank culture and fermentation in sequence.

5. A composition, characterized in that: Including the plant lactobacillus HYZQF 1675 iso-3 described in claim 1.

6. The composition according to claim 5, characterized in that The composition is in the form of lyophilized powder, injection, pill, tablet, capsule or gel candy.

7. The composition according to claim 5, characterized in that The composition includes an auxiliary material.

8. The composition according to claim 5, characterized in that The composition comprises one or more of water-soluble corn starch, anhydrous glucose, resistant dextrin, glycine and magnesium gluconate.

9. Use of the plant lactobacillus HYZQF 1675 iso-3 according to claim 1 or the composition according to any one of claims 5 to 8 in preparing a product; characterized in that: The product is any of the following: (1) Products for treating cancer, where the cancer is gastric cancer, colon cancer or cervical cancer; (2) Products that increase the content of one or more of asiaticoside, asiatic acid, kaempferol, glucoraphanin, ellagic acid, and glutathione in the intestine; (3) Products that inhibit mycotoxins, where the mycotoxins are aflatoxins; (4) Products that reduce the level of heavy metals in the blood; (5) A product for degrading pesticides, wherein the pesticide is trichlorfon.